Seven Eight Capital, LP Inari Medical, Inc. Transaction History

Seven Eight Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$40.68 - $58.62 $891,258 - $1.28 Million	21,909 New	21,909 $903,000
Q1 2024 May 13, 2024	BUY	$40.65 - $65.76 $423,166 - $684,561	10,410 New	10,410 $499,000
Q4 2022 Feb 13, 2023	BUY	$61.23 - $83.62 $375,278 - $512,506	6,129 New	6,129 $389,000
Q3 2021 Nov 15, 2021	SELL	$71.29 - $95.99 $277,175 - $373,209	-3,888 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$79.62 - $114.85 $343,321 - $495,233	-4,312 Reduced 52.59%	3,888 $363,000
Q4 2020 Feb 09, 2021	BUY	$60.0 - $87.29 $492,000 - $715,778	8,200 New	8,200 $716,000

283

56.4M

412K

46.7K

Ticker NARI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,389,700
Market Cap $4.27B
Description
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.